ScholarWorks@Hanyang University: Oh, Suk Joong

Detailed Information

Oh, Suk Joong (오석중)

COLLEGE OF MEDICINE (DEPARTMENT OF INTERNAL MEDICINE)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Chronic myeloid leukemia:4||Imatinib:2||Nilotinib:2||radotinib:2||CD8+ T cells:1||CML:1||Colorectal neoplasms:1||Dasatinib:1||Diffuse large B cell lymphoma:1||Dose modification:1||Drug resistance:1||Fentanyl:1||Head and neck cancer:1||Molecular response:1||Multidisciplinary communications:1||Neoplasms:1||Philadelphia chromosome positive:1||Postmarketing surveillance:1||Prognosis:1||Progranulin:1||R CHOP:1||RFC regimen:1||Recurrence:1||Response:1||Rituximab:1||Satisfaction:1||Suboptimal response:1||TOETVA:1||TORT:1||Thyroid cancer.:1||Tyrosine kinase inhibitor:1||chronic lymphocytic leukemia:1||chronic myeloid leukaemia:1||cohort study:1||dose determination:1||doseresponse relationship:1||imatinib:1||longterm data:1||low gammabutyrobetaine dioxygenase:1||lung cancer:1||machine learning:1||mortality:1||network metaanalysis:1||neutropenia:1||neutrophiltolymphocyte ratio:1||newly diagnosed:1||opioid:1||pegfilgrastim:1||prophylaxis:1||renal cell carcinoma:1||systematic review:1||thyroidectomy:1||Analgesics:1||tyrosine kinase  inhibitor:1||Asian countries:1||BCRABL1 mutation:1||Breakthrough pain:1||

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE